Eurofins Scient (OTCMKTS:ERFSF) Short Interest Up 63.2% in January

Eurofins Scient (OTCMKTS:ERFSF) was the target of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 141,869 shares, an increase of 63.2% from the January 15th total of 86,941 shares. Based on an average daily volume of 5,929 shares, the days-to-cover ratio is presently 23.9 days. Approximately 0.1% of the shares of the stock are short sold. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 5,929 shares, the days-to-cover ratio is presently 23.9 days.

Eurofins Scient Price Performance

Shares of ERFSF opened at $79.31 on Monday. Eurofins Scient has a 52-week low of $48.55 and a 52-week high of $86.20. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The stock has a fifty day simple moving average of $77.71 and a two-hundred day simple moving average of $74.81.

Wall Street Analysts Forecast Growth

ERFSF has been the subject of several research reports. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research note on Monday, February 2nd. BNP Paribas Exane raised Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Eurofins Scient currently has a consensus rating of “Hold”.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.